MyFinsight
Home
Blog
About
Kailera Therapeutics, Inc. (KLRA)
Kailera Therapeutics, Inc. (KLRA)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Balance Sheets Overview
Current Ratio
1110.77%
Quick Ratio
1110.77%
Cash Ratio
155.77%
Debt to Asset Ratio
7.67%
Unit: Thousand (K) dollars
Assets Breakdown
Marketable securities
Long-term marketable securities
Cash and cash equivalents
Others
Liabilities Breakdown
Additional paid-in capital
Accumulated deficit
Accrued expenses and other curre...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Balance Sheets
2026-06-30
2026-03-31
Cash and cash equivalents
130,301
111,826
Marketable securities
786,440
407,348
Prepaid expenses and other current assets
12,426
11,141
Total current assets
929,167
530,315
Property and equipment, net
1,753
1,854
Restricted cash
761
761
Long-term marketable securities
255,076
62,747
Non-current clinical deposits
14,671
13,318
Operating lease right-of-use assets
9,898
10,170
Other non-current assets
90
5,591
Total assets
1,211,416
624,756
Accounts payable
19,202
7,095
Accrued expenses and other current liabilities
63,399
46,714
Operating lease liabilities, current
1,050
1,027
Total current liabilities
83,651
54,836
Operating lease liabilities, non-current
9,166
9,443
Other non-current liabilities
135
201
Total liabilities
92,952
64,480
Convertible preferred stock-Series AConvertible Preferred Stock
0
390,306
Convertible preferred stock-Series BConvertible Preferred Stock
0
602,058
Preferred stock
0
-
Common stock
0
0
Additional paid-in capital
1,679,098
15,977
Accumulated other comprehensive (loss) income
-1,794
-532
Accumulated deficit
-558,840
-447,533
Total stockholders' equity (deficit)
1,118,464
-432,088
Total liabilities, convertible preferred stock and stockholders' equity (deficit)
1,211,416
624,756
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Marketable securities
$786,440K
Cash and cash
equivalents
$130,301K
Prepaid expenses and
other current assets
$12,426K
Total current assets
$929,167K
Long-term marketable
securities
$255,076K
Non-current clinical
deposits
$14,671K
Operating lease
right-of-use assets
$9,898K
Property and equipment,
net
$1,753K
Restricted cash
$761K
Other non-current
assets
$90K
Total assets
$1,211,416K
Total liabilities,
convertible preferred stock...
$1,211,416K
Total stockholders'
equity (deficit)
$1,118,464K
Total liabilities
$92,952K
Accumulated deficit
-$558,840K
Accumulated other
comprehensive (loss) income
-$1,794K
Additional paid-in capital
$1,679,098K
Total current
liabilities
$83,651K
Operating lease
liabilities, non-current
$9,166K
Other non-current
liabilities
$135K
Accrued expenses and
other current...
$63,399K
Accounts payable
$19,202K
Operating lease
liabilities, current
$1,050K
Buy us a coffee